Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge.
Infect Control Hosp Epidemiol
; 42(1): 84-88, 2021 01.
Article
in English
| MEDLINE | ID: covidwho-1003194
ABSTRACT
We observed bacterial or fungal coinfections in COVID-19 patients admitted between March 1 and April 18, 2020 (152 of 4,267, 3.6%). Among these patients, mortality was 57%; 74% were intubated; 51% with bacteremia had central venous catheters. Time to culture positivity was 6-7 days, and 79% had received prior antibiotics. Metallo-ß-lactamase-producing E. cloacae coinfections occurred in 5 patients.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Bacteremia
/
Coinfection
/
SARS-CoV-2
/
COVID-19
/
Anti-Bacterial Agents
/
Mycoses
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
Limits:
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
North America
Language:
English
Journal:
Infect Control Hosp Epidemiol
Journal subject:
Communicable Diseases
/
Nursing
/
Epidemiology
/
Hospitals
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS